| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.06 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.07 | 0.06 |